Good afternoon and welcome to Qt Group's Q4 2025 results presentation. My name is Heli Jämsä?]

, IR Lead, and with me today are our CEO, Juha Varelius, and interim CFO, Ann Zetterberg, to present the results. After the presentations, we will have Q&A first in the room, and if there's time left, move on to the questions from the lines.

Without further ado, please, Juha, the floor is yours.

Thank you. Good afternoon, everyone.

We have a same agenda as always. I go a bit through what happened on Q4, and then Ann is going to go through the numbers in more detail.

I talk a bit about the future outlook, and then questions. The Q4, we had a growth of 12.6% or 18.6% comparable currencies, and of course, IAR acquisition, which we completed, contributed in this development.

IAR was €8.1 million on Q4, and our organic growth was 6.1%. Compared to the very difficult year we had last year, it was a decent quarter, and we were happy on that.

Our EBITDA margin was 35.6% and €27.5 million, and there is a decrease compared to last year, but we did have a one-off costs on the acquisition that were burdening that. I'm going to talk more about the overall market environment, but of course, even the year changed, the market environment hasn't changed that much, we had a quite a bit challenges last year, which affected our customers in a way that we had tariffs and whatnot, uncertainties.

Selling developer licenses last year was slow, if put it on one one word. On the whole year, we ended up on €216.3 million, which is a increase of 6.6% on comparable currencies, we went pretty much in the middle of our guidance.

The distribution license revenue grew very well last year. There were a lot of new things coming into the market, new programs started, which ended up on the 26.4% growth, and of course the main industries for distribution licenses is the automotive, medical, and industrial manufacturing.

The whole year EBITDA was €51.8 million, and there was a decrease. EBITDA margin was a 24%.

Our personnel increased end of the year to 1,100, out of which 215 are IAR employees, but we did continue our own hiring as well. The one-off costs for IAR acquisition, €5.8 million.

We're going to talk that also a bit later, but of course we all know that the IAR profitability has been less than the Qt, so that affects the overall profitability of the group going forward this year. We haven't disclosed the ARR before, and on the ARR, we had a growth of 8.3%.

There on the small print is that it is Qt and QA developer license based, and it does not include the IAR licenses and distribution licenses. That ARR is the Qt and QA business.

We plan to give that ARR number now in a future also in the half-a-year sequence so you can see that, because one of the questions affecting our revenue has always been the shift from one to three-year licenses. Of course, last year we did see the cautiousness in our customers, it was slowness in sales, but it was also people shifting from three-year to one-year.

Now presenting this ARR, you don't have to worry about the shift from one, three-year to one-year, because we can follow the ARR. Our plan is to give that number now next time after second quarter and so on.

Obviously, it's a number that doesn't change that much. We might even go on a quarterly basis if that's needed, but like said, it's a much slower-moving measurement.

Here are some of the product-related things we did in 2025. There are always questions about AI.

Is AI going to eat our lunch in a way that there are a lot of predictions on AI that no developers are needed and AI is going to do all the code. At least as of now, we don't see that development.

We do see that there are a lot of AI assistants being used, like we are offering them in Qt and our design studios and on Squish. On writing test scripts, for example, you can use AI, and then the Squish does the actual testing.

They help on that. Do we see that specifically on embedded world, that the AI would become and replace the developers, that kind of development we don't see as of yet.

At the same time, of course, it's good to realize that I think that the US companies are planning to invest $500 billion, $600 billion next year, obviously they are expecting to get something out of it. I don't see that developers would be going away next year or even in the coming years in that sense.

On partnering side, on Axivion, we do have a partnerships with NVIDIA CUDA, when you're doing CUDA code or using CUDA, you can use the Axivion. On the R&D, on the defense sector, we did have the FACE certifications and working with Infineon over there on the AI consumer powered devices, and then we're expanding our ecosystem through the Qt Bridges, which will enable more languages over there basically.

These are just some of the highlights that we're working on the product development. In general, all our products have always been very good.

We get a very good feedback, this is just to show a few examples that we do continue our R&D, and we are on the forefront of product development all the time making sure that all the Qt products are very competitive in a market. That seems to be the case on all the customer surveys from our users.

With this, Ann, please.

Good, thank you.

Some numbers.

Yes. Yes, I am Ann Zetterberg.

I have been the CFO of IAR, I'm on my fifth year now. With the acquisition of IAR, I had the opportunity then to step up and become the interim CFO for Qt.

I'm going to tell you a little about the numbers then for this quarterly report. Delighted to meet you all.

There will be a bit of a P&L first, maybe a little repeat on what Juha just mentioned. In Q4, we had a growth of 12.6%, and after exchange rate impact, it was 18.6% at comparable currencies.

The organic growth with removal of IAR revenue, which was €8.1 million, that was 6.1%. For 2025, the growth was 3.5%.

Exchange rate impact has been pretty bad both for Q4 and for the full year. Especially the dollar has behaved very very badly for us.

The growth there for 2025 at comparable currencies was 6.6 percentages, and the organic growth was 2.6%. As Juha also said, we plan to show the ARR as that shows better the yearly underlying growth for the company.

It's not affected from which contract length the customers chooses. As we recognize 95% of the contracts upfront, it matters a lot if they choose a five-year contract or a one-year contract for revenue.

ARR illustrates the underlying growth very stably, and that is growing good for us. It was 8.3% of growth for the Qt part, excluding IAR during the year.

Then looking at expenses, the personnel year-on-year grew by 267 individuals. That's a growth of 31%, but of course a lot of that relates to the IAR acquisition.

215 people worked at IAR at acquisition. That increased the head count to 1,136 both on average for the year, but also at the year end.

IAR contributed €4.8 million in staff costs in the P&L. Under other OPEX, the IAR acquisition had some extra costs then, €4.1 million in Q4 and €5.8 million during the year.

Also I wanted to highlight, even though it's a very small cost, the capitalized assets, as IAR has interpreted IAS 38 a bit differently than Qt has and has capitalized R&D assets in the balance sheet. Presently, there is €5.4 million of capitalized unfinished assets in the balance sheet of IAR, and those are expected to be finished under 2026.

This means that we will have a small positive effect on the P&L from this capitalizations, removing costs and putting it into the balance sheet. I don't expect any large amounts from this, but it's still good to understand that this is what it looks like now.

Over time, there will be some harmonization within the group so all companies look at this in the same way. Then, of course, the profitability, like Juha just mentioned, has gone down.

The EBITDA margins are lower both for Q4 and for the year. IAR has a lower profitability, so that contributes to that, and as does the acquisition costs.

Of course, when you join two companies, there are also opportunities for integration efficiencies and cost reductions, which we are going to work on starting this year. This means that the earnings per share has gone down to 0.73 for the quarter and 1.25 for 2025.

Then moving on to the balance sheet, a lot has happened to the balance sheet, obviously, from the acquisition of IAR. The preliminary PPA added €204 million in net assets to the balance sheet.

Of that, goodwill was €122 million. Then there were identified other intangible assets of almost €90 million.

Those were customer relations, technology, and trademarks. Those will be written off over 15 years, the amortization yearly net of tax would be €4.8 million.

Also the acquisition added other net assets of €11.2 million in IAR, some of those assets on the assets side of the balance sheet and some on the debt side, sort of spread over. The net of them all are €11.2 million.

Some of those assets were trade receivables then, which increased the trade receivable balance to €58.7 million in the balance sheet. There are also other receivables, which could be good to know, one booking of €5.1 million, as we have booked the full value, 100% of the shares to the balance sheet, as there is arbitrage going on and we are obligated to buy the rest of the shares.

We are not showing any minorities under equity, because it's only a matter of time until we own 100% of the shares. That can also be good to know.

Then the ending cash balance was €40 million, €40.1 million, a little lower than compared to last year as we have made this large acquisition. As the balance sheet has expanded, the equity ratio has gone down from 81% to 50%.

Also the interest-bearing debt has increased. The interest-bearing debt is €143.2 million, and of those, €134.4 million are debt relating to the acquisition of IAR.

We have paid off some of the debt already. It was €150 million to begin with.

Also on the deferred tax on the debt side relating to those intangible assets that were €90 million on the other side, there's also deferred tax booked on the other side, which is €18.5 million, good to understand also how the PPA affects the balance sheet. Under short-term liabilities, there is a debt of €5.1 million, which is the amount we expect to pay for the remaining shares of IAR after the arbitrage is finalized.

Then I can just, as a final note, say that the operative cash flow then had gone down a bit, but mainly because of the profitability going down. Nothing strange about that.

With that, I suppose I am done with the financials, and we will take questions afterwards, but I will then leave to you, Juha,

to

take the next of the slides. Yeah.

Thank you.

Yeah. So,

2026. I think the first big thing is that the during the next three years, as the IAR has been on a perpetual model, and our, during the next three years, we are, our our target is to to shift that into subscription model.

That's roughly the, by the way, the same plan we did have the early on with Qt when we did this a few years back. If this goes as planned, the the IAR revenue will be going down this year.

It's going to be decreasing this year, and then depending on how aggressively that goes down this year, then the swing back will be bigger next year. It's the early phases, the we've started the journey.

We have now couple months behind us, it's the to make a exact predictions at this point is there is a bit of a room for that estimate still. I think the market's been uncertain so long that the uncertainty will definitely continue, as we know there are a lot of global tensions going on as we speak, and that's what we're looking this year.

Some of our customers are in a challenging environment. Like in automotive, the Chinese automotive manufacturers are putting a pressure on the on on the European manufacturers, and at the same time there are tariffs, that's obviously going to continue all this year, and so on and so forth.

I think that on industries, the automotive will be in challenge, medical will not so, and the industry automation seems to be doing pretty well, defense is doing really well. In if I now look the two of our biggest industries, they are actually medical and defense at this point of time.

They've grown quite substantially over there where they've been. The long-term growth prospects, well, like I said on the AI, this software really defines the value of the products.

Each product will have software going forward, and the new versions of it. We don't see on embedded that the the AI would be eating all that market away far out from that, but we do see AI improving our own products on on many respect, and and that's what what we are implementing.

Before we've given our estimates that we've given you a range, but we gave up on that range. Now we're saying that our full-year net sales will increase at least 10%, we're saying that that's the floor, but we're not giving a range, we're not giving the upper part guidance.

That's a bit different. We're saying that our operating profit margin will be at least 15%, again we're saying that that's the floor, we're not giving the upper range.

We're not giving those ranges anymore. Going forward, we're going to start after Q1 or at the Q1, we're going to start giving you more info on how, well, we will start sharing this ARR, which will give you a better understanding.

You don't have to worry about the shift on the three to one-year licenses. Then we're looking that we're going to give you more on the revenue per product so you get a better understanding on how the distribution licenses are coming, we're looking to open up that a bit.

I don't know if it going to make your life any easier, because there is a lot of fluctuations, but at least you can then see that fluctuation. We've been listening what you've been asking, and so, but more to come on that later.

I think the ARR actually will help you more than seeing the distribution license sales and whatnot, but more of that. Do you have any questions?

Okay.

Good afternoon, it's Matti Riikonen, DNB Carnegie. Couple of questions.

They are very simple. Do you expect the legacy Qt business to decline in 2026?

Simple answer: no.

Okay. Do you have a rough estimate of how much IAR's revenue would decline in '26 versus '25 if you give a broad range?

You say it's going to decline and you say that you don't know yet, but roughly where are your thoughts at the moment?

Double-digit.

All right.

Low.

Third question before I give the mic to somebody else, how will IAR's fixed cost base develop in 2026?

Simple question, longer answer. We're not looking to increase the IAR cost base.

What what you're going to see now is that the IAR, the the revenue decline really depends on the on on the how well can we go on a subscription, and we try to go as aggressive as possible. If if I say low double-digit revenue decline somewhere there, right, I don't know yet, but somewhere there.

Then 2027, I do expect to see a double-digit, high double-digit growth on the, maybe close to 20-something, to give you an idea how it roughly could work, right? On a cost level, when we when we see costs, obviously we not going to be increasing costs because the prices are increasing, right?

We do have some R&D-related initiatives over there where we think that we're going to be increasing cost, and they are related into the fact that IAR is very much on a functional safety safety-critical environments in automotives and whatnot. We're looking for a product development that we can broaden that segment roughly to put on a broad perspective.

Then we have a few places where we're going to, mainly on sales, we're going to increase sales costs. We're talking very modest cost increases on the IAR side.

If you look the old IAR and now you have the numbers from there, we're looking very, we're looking some cost increases, but fairly modest over there. Still, if you model that the revenue development on IAR numbers with that revenue dip, you're going to be seeing that the EBITDA contribution for the whole group this year is going to be pretty much break-even or even slightly negative.

We're not looking for, first of all, on the guidance, we those are the bottom lines, they are the floors, they are not the we see that that's the bottom bottom, right? We do expect a bigger numbers.

Then the the IAR negative contribution will be on this year, but when it swings next year, we don't, there is no need to increase costs the for for that, because it's basically a price increase. It'll swing the IAR EBITDA, well, it's a license sales, everything that the revenue will be increasing will go directly to bottom line.

That's the that's the implication. On Qt Group, well, you called it legacy group, the time changes.

We'll figure out a better name than legacy. Anyway, the old Qt, we're not expecting organic decline, and we're not expecting that the what we saw last year, the the bottom line, we're not expecting there to see a decline in EBITDA that we had last year.

That's the bottom performance, right? We expect that the bottom performance be last year level and higher on there.

That's kind of the the overall picture. It's maybe not that gloomy than you were first thinking.

I don't know how gloomy you were, but that's my my educated guess. Thank you for the simple questions.

Thank you. That's all for me so far.

Hi, Jaakko Tyrväinen from SEB. On distribution licenses, what happened in the sales in Q4 since I recall that the commentary after the first nine-month performance was rather moderate also in this revenue stream.

I'm curious whether there were some customers filling up their inventories in terms of distribution licenses, and how should we look at the revenue stream for '26?

Thanks. Maybe later on on a first Q when we open up the product distribution, you're going to see, but the distribution licenses is really hard to predict because it's not like this.

Quarter on quarter like last year, it went, well, first quarter, second quarter boom, and then up again. That changes every year, the quarters are not alike.

You can't expect that what was last year on second quarter is going to be the same, and that makes it very difficult. As the distribution licenses go that some customers buy them afterwards, telling that how much they shipped, and some people buy a chunk on pre-buy.

That's why it's hard to predict. On general level, we know that some big new productions are coming into the market, then we know on a yearly level what's going to happen.

Last year was on that sense very good. If you look last year numbers and distribution licenses for this year, I would take them slightly down.

That's my expectation for this year, given the market volatility, what's the customer demand in Europe and whatnot. At the end of the day, our distribution license revenue comes from a product what the consumers are buying, right?

That's, in a general terms, it follows. We are on a 70 industries.

We are both on commercial devices like industry automation, robots, and whatnot, stuff that goes into hospitals, stuff that goes into factories, but also on consumer goods like auto, cars and whatnot. That's where the fluctuation really comes.

I would not put on my model same growth this year than we had last year. This is going to be substantially lower.

Same number or a bit below, that would be my best guess, and that's a guess.

Understand very well. Just to confirm, Q4 was strong in distribution licenses?

Oh, yeah. It was a good.

Last year, on distribution licenses, Q2 was very good, Q3 was very weak, Q4 was good, yeah. Q2 was, if I remember correctly, the best on distribution licenses last year.

Does not mean that that's going to replicate. It really goes like this.

Good, thank you. Then on the ARR, thanks for sharing that to us and the growth of 8% there.

Could you give some color on how much of this was pricing, and how much was coming from the effect that customers changed from three-year to one-year, which obviously should have kind of positive pricing impact on the annualized ARR number?

Oh, that very good and detailed question that those numbers I don't have. We can come back later, but those I don't have out of my head.

On general level, I can say that there was some shift from three-year to one-year, if I look on a whole-year number, but it's slowing down. That shift is slowing down.

Definitely what we saw through all the year was the fact that on renewals, what people used to do is that they had something, and then they renewed all the licenses. Nowadays, customers are counting that how many developers we really have, how many licenses we really need.

In general, money has been very tight. Our customers are very tight on money.

They're looking all the costs, and many R&D budgets are such now that the R&D budgets are not growing, if they do something additional, they need to stop doing something old.

Good, thanks. Then my final one on the on the possible AI disruption also in the in the embedded side.

I heard what you said, but could you give us or for kind of for a dummy explanation why why the embedded world, what are the barrier entries for AI native solutions to to break in?

As of today, what we see, first of all, that you have a lots of safety-critical, you have lots of functional safety type of things like car brakes and whatnot. You need certificates, and and there are, there is a very tight regulation what do you need in order to have software, you can't just ask AI that do me a car brake system, thank you, and implement it, right?

The second is that the on embedded, the software goes into products, right? In products, if you need to do a product recall, that is really really expensive, you have to be fairly certain that what you're doing.

The third is that the the embedded is a fairly slow-moving. There are huge companies building these cars and and all these devices, medical devices and whatnot.

The the the time of the change and how secure they need to be that if I'm building this medical device, that nothing really goes wrong. They change relatively slowly, right?

Whereas if you think that on a website that I want to do a mobile application, I do a mobile application, if it works, great. If it doesn't work, it doesn't matter so much.

It's kind of a different environment. Then if you think about coding, just building the software is is, it's one part of the process.

You need to define what you want, you need to discuss with people that what are we building, what this product is doing, and on and on and on. AI is definitely not ready for that yet, right?

Where it's really going to end, we'll see, but that's what we see as of today. They are, we see AI as assistants, and, like if you're designing something, you can use AI to give you creative ideas, because as people, we tend to start looking, one-way street.

AI can open up your creativity and whatnot, but yet you're still using tools. My prediction is that the the next phase you're going to see on on SaaS environment and the products like ours is yet another pricing change.

We're doing this just to mess you up, right? Yet another pricing change.

The pricing change is going to be that the the pricing, I think, is going to go more towards from that the what has been built, how much the tool has been used rather than a dev seat, right? That's that's where I see the AI is going.

I I I had a one breakfast discussion, and the the person pointed out that the, "Remember couple years back," this person said to me that, "Remember couple years back, everybody in Finland were talking that the even grandmas need to learn coding, because software is in every device, and everybody needs to learn how to code so that we can use these products, and there were all kind of coding schools started and whatnot." That was two years ago.

Now everybody is talking that developers are, nobody needs developers anymore. There is a bit of a hype on the speed of the change.

Over time, of course AI is going to, 10 years from now, AI has changed a lot how we work, but and live our lives. In a near future, I don't see a much of effect.

Then on the, and this is the Qt development, right? On the IAR compiler business where you need all the certificates and whatnot, there is no way you can use the AI for a long time.

Then on our testing tools, well, whatever you do with AI, you need to test, I see that there's going to be more and more software that needs to be tested, because you can't rely on AI. The testing business is going to grow substantially as a market.

Excellent, thank you.

Hi, Felix Henriksson, Nordea. Three questions.

Firstly, on Q4, the revenue growth organically accelerated a little bit, and we've discussed about the distribution licenses being strong, but was there anything else that improved? For example, the lack of large deals that we saw in earlier quarters, did those sort of come back at all?

No. No, if I look on the regions, I would say that we're doing well in APAC, we're doing okay in Europe, we have room for improvement in Europe in some markets.

Then in general, we have lots of room to improve in US. The maturity of our softness been in US.

Then we come to the point that if we talk about the AI, or if we talk about that is there a competing product, or is there a price change, what I see in a markets is that we're doing fine in APAC, we're doing fine in Europe, and the main softness we have is in US. Even in US, we have some teams that are doing okay, but then some teams are really suffering in that respect.

That's why I'm fairly confident that it's not about AI eating our market, because if it would be, it would be eating our market everywhere globally, right? This is more a local softness we are having.

Same thing for prices and competition, because we have same type of, in APAC, we have the same industries and same type of customers we have elsewhere. Our softness basically has come last year that we've been a bit soft, it's been a US-related, right?

I'm very confident that we can fix that and get the efficiencies over there on a better shape.

Right, and then on the guidance, you mentioned that you're no longer giving those ranges, you don't have the upper end. Can you expand on that a little bit, what's changed with your guidance philosophy in a way that triggered that change?

Yeah. I wasn't very good at that last year.

Maybe more conservatism in that way.

Absolutely. Hey, we gave two profit warnings.

Was not on my plan.

Fair enough. Very clear cut.

Yeah.

Lastly, on distribution licenses, we've started to see memory prices going up and there are some supply constraints emerging that potentially are impacting your customers, I presume. Do you think that's a sort of potential headwind when you look ahead, and what are customers saying when it comes to this?

No, that's a downwind, because that's where Qt really shines. The fact that if you use Qt, you can do more with less memory.

That's been the basic promise since the beginning. With Qt, you can have the same performance with the lower-end hardware, and that's the main selling point we're having as of today.

Higher price is better for us, because at the end of the day, our customers will have to build those products anyway. Then it's a greater question of what kind of performance they want, what kind of end-user experience they want.

That's where we shine. That's where, like Android doesn't shine, right?

You use Android and you need a lot more hardware than using Qt, and so on and so forth. Same goes with Unity.

Most of our competitors, they may be in some use cases like Unity, Unreal, they might be able to do a better 3D visualization, or it looks better. It consumes so much hardware that if we go on a lower-end hardware, we can beat them.

You can get a fairly good performance and a lot lower hardware using Qt. That works for our benefit.

Thank you.

Hi, it's Atte Riikola from Inderes. One question.

We know that the last year's growth was quite sluggish and there is still uncertainty around this year. Is that affecting your own investment plans, or are you just keep on going with all the growth investments that you have planned before?

Yeah. We will continue our investments, yeah, for sure.

No doubt about that. We do have this few areas where, well, first of all, I think that we wouldn't be here in the first place if our products wouldn't be so competitive.

We need to keep them in that way. Then, of course, we are exploring the opportunities that the AI is opening up, and we need to do product development to have AI agents in our own products, and so on and so forth.

You're going to hear product releases as we go forward this year. Definitely we're going to do that.

Then at the same token, like Ann was saying over here, that we just merged two companies, and of course we're going through all the processes. We're going through where can we be more efficient.

We've grown very fast. We're 1,200 people, and so we do have also to efficiency programs if you like, but it's not all more, it's also efficiencies at the same time.

That's very much on Ann's table as well.

Thank you.

Hi, thanks for the presentation. Waltteri Rossi from Danske Bank.

Few questions about AI. Did I hear correctly that you said that you might change your pricing model in the future due to AI?

Yes. I said that that's probably going to be the first change that we see on AI, that the SaaS models pricings will start changing more based on the consume of the tool rather than the dev seat.

I did not say that we're going to do that change, and I did not say that we're going to do that change this year, but I said that that's what I see that how AI is going to be affecting SaaS companies in general, that the pricing will change as going forward. I don't see that AI will be taking over the tools business per se.

I understand, but no timeline

for No.

Okay. That would imply in a way that there is at least a big threat on your developer license sales from AI.

No, I don't see it that way. I see it that that's going to be the effect that the SaaS business will go more towards that people are charged that how much you use the tool rather than per dev seat.

I see that development coming, but no timeline, definitely not this year, next year or so. No.

Okay. Next one still on AI.

What would you say is basically Qt's value proposition for the customers, because there's the argument that the AI will make developers work more efficient. That's kind of eating up one of your value propositions.

Mhm.

What else do you basically offer for the customers?

We offer a tool that they can build their graphical user interface or applications, and as we are here today, AI is not capable of that. You need the human, and you need the tool.

Then it's debatable that when will AI be able to do that, if ever. Then we see that if you need certifications, you need like on defense, like in automotive, on many industries, on medical, there's a long list certifications you need to meet.

Who's going to train an AI that will meet those certifications and make sure that AI does the things every time in that particular manner and everything is met? That's years away, if ever.

Agree, but still on that actually a follow-up. We know that programmers are already today using AI assistants, but are you saying that you don't see your customers yet using them?

No. You see a lot of developers using AI on a web technologies.

If you want to do a simple mobile application, you can do that. Or you want to do web pages, you want to do your own home page, you can use AI for that.

Of course, they are so simple that if you want to do your own web page, they are on a web already. What AI does is that it takes a web page, and then it produces a new web page, right?

That you can do, yeah. On embedded, building on products, no.

One last on on AI. Can you please elaborate how how Qt is currently using AI in in the framework?

Or do you have a have add-on or something?

Yes, you can have add-ons. You can have assistants over there that helps you getting started.

For example, on testing, you can use AI that it helps you doing this testing script and these type of things. It helps you kind of think that it helps you building a bit of a story or text, but yet still you have to read it and modify it.

That's what we see as of today, yeah.

All right. Then one last question on the usual one to three-year licenses.

Do you have a number on how much that shift from three-year licenses to one-year licenses impacted last year's sales?

No, but we're going to give you the ARR, you can start follow that.

Yeah. Thank you.

Matti Riikonen, DNB Carnegie. Couple of questions more, they are even more simple.

You discussed the capitalized cost policy so that you would basically go towards Qt's policy, which I read that you would not any longer capitalize some costs that IAR has. Should we expect that there would be none whatsoever on the capitalized costs in '26?

In '26, there will be still. Because we have unfinished assets in the IAR balance sheet, and we need to continue capitalizing on those according to IAS 38.

Right.

There will be some capitalization of R&D assets during 2026. We expect that those will be finished under 2026, the assets that are not finished.

After that, we will harmonize between the companies so we can find a common application of IAS 38.

You want to come over here so we have you on a camera as well.

Yes, about the capitalizations, since Qt and IAR has handled the IAS 38 application very differently. IAR has been capitalizing R&D assets into the balance sheet, which increases the profitability, and then you write off the assets over time.

After the acquisitions, we kind of cleaned out the balance sheet. The assets that are not finished, they are still there, and we will have to follow IAS 38.

We will have to continue to capitalize on those until they are finished. Otherwise, we don't follow the bookkeeping rules correctly, and we don't want to break them.

That will happen. In that time, we will evaluate and harmonize between the companies so we can have a common approach to this.

Then I expect that we will not capitalize anymore, but I cannot 100% tell you that that will happen. We will have to have a common approach anyway within the group on how we handle this.

A joiner, yeah.

What kind of magnitude of capitalizations do you think there would be in '26?

It will not be a lot. Those assets are almost finished.

They're €5.4 million there now. I don't expect there to be any huge capitalizations.

As you saw during Q4 on those assets, we capitalized €200,000, it wasn't a lot. It can go up and it can go down a little depending on how much work the R&D department puts into various projects.

I don't expect it to be anything that affects the profitability much, but it can be good for an analyst to understand that this is a difference from how Qt has handled it before.

Right, thank you. That's helpful.

Then

second question is about the annual recurring revenue disclosure that you plan, which is an excellent idea. How long into the history will you bring that?

Is it possible that you would bring maybe a couple of years history so that we could start to track it already from there and not just from here on, because of course in the ARR pattern, the history is what counts, and current day is less interesting if you don't know the history.

Oh, we already gave the last year number, right?

That's not a very long history.

It's the last year. Yeah.

We'll look into that, yeah. Great question.

We didn't

think it that way, but we'll look into it.

All right.

On capitalization, it's like Ann said that there are a few projects we need to continue, but of course in general, going forward on a longer term, we're not looking to capitalize. We rather implement the Qt policy going forward and not capitalize the development, yeah.

All right. I think

it's a better way.

Very good, thank you.

Mhm. Jaakko Tyrväinen, SEB.

A brief follow-up on the profitability dynamics and IAR part of that. Let's say the revenue is down double-digit something, like you said, Juha.

Would this imply that IAR as a standalone would be at break-even or even red numbers in '26?

Red.

Thanks.

Sorry, one last one from me. You said you are going to continue

You were?

Sorry? Waltteri Rossi, Danske Bank.

Thank you.

Thank you.

You said that you are going to continue recruiting this year, could you elaborate a bit on where exactly are you going to recruit?

Or

you said invest, but the question may be this.

Regionally or by function?

Say again, I didn't quite hear.

Do you mean regionally? We do have few markets where we're going to be increasing personnel.

Probably the UK is one, and these are small numbers, but then they add up. For our Italian business, more or less.

In Japan, we're going to be increasing the personnel. The China, probably.

In particular markets, I think in US, we pretty much on a head count we like to be at this point of time. On R&D, there are these new technologies like the one that interests you a lot, which is the AI, of course on these new technology areas, we instead of trying to learn them ourselves, we are hiring people, we do have some of these new technology areas.

If I look in general on the R&D, the Qt is very well staffed. The QA business function itself, it's still on the investment mode, over there you're going to see pretty much on each and every function, a bit of marketing, a bit of sales, a bit of product management, a bit of the R&D.

On IAR, we are strengthening some of the R&D functions over there, IAR I would say that the most personnel additions will be on a product R&D side, and then some on sales. When you have so many different locations, you add up, and then you get the personnel increase.

That's basically what we're looking for.

Thank you.

Mhm.

Thank you so much. I believe that concludes all the questions from the room, and as we are running out of time, I give it back to Juha for closing remarks.

That came quick. Thank you very much for being here today, and as we go into this year, like I said, the very big item for us this year is going to be the subscription change on IAR, going from perpetual to subscription.

That's the one of the core things we're doing, and, of course, integrating IAR into the Qt family, we're going to be a bigger, happy family. We're also looking forward this year that, yes, it's going to be challenging year.

I like to emphasize that the guidance we gave was not a range, we just gave a bottom line that what is the floor level where we expect to be this year. Of course, we are expecting to be better on those numbers.

On a profitability side, we're not looking on Qt to decrease on profitability, nor on sales, but the IAR subscription change will affect our profitability this year, and so that's why the lower guidance. Where it's going to end up then, that how aggressive can we be, remains to be seen.

In any case, the 2027 for IAR will be a revenue growth year and a profitability year, then the question is that how steep is that curve over there. Still very early phases to see that how rapidly we can drive this subscription change.

I think with these words, thank you very much.